150 related articles for article (PubMed ID: 31492960)
21. Rising Influence of Nanotechnology in Addressing Oxidative Stress-Related Liver Disorders.
Padmanaban S; Pully D; Samrot AV; Gosu V; Sadasivam N; Park IK; Radhakrishnan K; Kim DK
Antioxidants (Basel); 2023 Jul; 12(7):. PubMed ID: 37507944
[TBL] [Abstract][Full Text] [Related]
22. Exploring the Long-Term Tissue Accumulation and Excretion of 3 nm Cerium Oxide Nanoparticles after Single Dose Administration.
Ernst LM; Mondragón L; Ramis J; Gustà MF; Yudina T; Casals E; Bastús NG; Fernández-Varo G; Casals G; Jiménez W; Puntes V
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36979013
[TBL] [Abstract][Full Text] [Related]
23. pH-responsive theranostic nanoplatform of ferrite and ceria co-engineered nanoparticles for anti-inflammatory.
Dou Y; Zhang Y; Lin C; Han R; Wang Y; Wu D; Zheng J; Lu C; Tang L; He Y
Front Bioeng Biotechnol; 2022; 10():983677. PubMed ID: 36159657
[TBL] [Abstract][Full Text] [Related]
24. Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway.
Li R; Li Y; Yang X; Hu Y; Yu H; Li Y
J Transl Med; 2022 Jul; 20(1):341. PubMed ID: 35907871
[TBL] [Abstract][Full Text] [Related]
25. How Does Immunomodulatory Nanoceria Work? ROS and Immunometabolism.
Ernst LM; Puntes V
Front Immunol; 2022; 13():750175. PubMed ID: 35401546
[TBL] [Abstract][Full Text] [Related]
26. Understanding Nanomaterial-Liver Interactions to Facilitate the Development of Safer Nanoapplications.
Li J; Chen C; Xia T
Adv Mater; 2022 Mar; 34(11):e2106456. PubMed ID: 35029313
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of cerium oxide nanoparticles in non-alcoholic fatty liver disease (NAFLD) and carbon tetrachloride-induced liver damage in rats: Study on intestine and liver.
Abbasi E; Vafaei SA; Naseri N; Darini A; Azandaryani MT; Ara FK; Mirzaei F
Metabol Open; 2021 Dec; 12():100151. PubMed ID: 34870139
[TBL] [Abstract][Full Text] [Related]
28. Cerium Oxide Nanoparticles Alleviate Hepatic Fibrosis Phenotypes In Vitro.
Boey A; Leong SQ; Bhave S; Ho HK
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769206
[TBL] [Abstract][Full Text] [Related]
29. The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review.
Moosavian SA; Sathyapalan T; Jamialahmadi T; Sahebkar A
Bioinorg Chem Appl; 2021; 2021():4041415. PubMed ID: 34659388
[TBL] [Abstract][Full Text] [Related]
30. Cerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases.
Casals G; Perramón M; Casals E; Portolés I; Fernández-Varo G; Morales-Ruiz M; Puntes V; Jiménez W
Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33923136
[TBL] [Abstract][Full Text] [Related]
31. The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.
Abou Assi R; Abdulbaqi IM; Siok Yee C
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806527
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity, Retention, and Anti-inflammatory Effects of a CeO
Eilenberger C; Selinger F; Rothbauer M; Lin Y; Limbeck A; Schädl B; Grillari J; Kavok NS; Klochkov VK; Malyukin YV; Margitich V; Ertl P
ACS Pharmacol Transl Sci; 2021 Feb; 4(1):101-106. PubMed ID: 33615164
[TBL] [Abstract][Full Text] [Related]
33. Transcriptomics- and metabolomics-based integration analyses revealed the potential pharmacological effects and functional pattern of in vivo Radix Paeoniae Alba administration.
Wang S; Chen H; Zheng Y; Li Z; Cui B; Zhao P; Zheng J; Lu R; Sun N
Chin Med; 2020; 15():52. PubMed ID: 32489401
[TBL] [Abstract][Full Text] [Related]
34. Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma.
Fernández-Varo G; Perramón M; Carvajal S; Oró D; Casals E; Boix L; Oller L; Macías-Muñoz L; Marfà S; Casals G; Morales-Ruiz M; Casado P; Cutillas PR; Bruix J; Navasa M; Fuster J; Garcia-Valdecasas JC; Pavel MC; Puntes V; Jiménez W
Hepatology; 2020 Oct; 72(4):1267-1282. PubMed ID: 31961955
[TBL] [Abstract][Full Text] [Related]
35. Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice.
Bubnov R; Babenko L; Lazarenko L; Kryvtsova M; Shcherbakov O; Zholobak N; Golubnitschaja O; Spivak M
EPMA J; 2019 Dec; 10(4):317-335. PubMed ID: 31832109
[TBL] [Abstract][Full Text] [Related]
36. Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes.
Carvajal S; Perramón M; Casals G; Oró D; Ribera J; Morales-Ruiz M; Casals E; Casado P; Melgar-Lesmes P; Fernández-Varo G; Cutillas P; Puntes V; Jiménez W
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783479
[TBL] [Abstract][Full Text] [Related]
37. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.
Carvajal S; Perramón M; Oró D; Casals E; Fernández-Varo G; Casals G; Parra M; González de la Presa B; Ribera J; Pastor Ó; Morales-Ruíz M; Puntes V; Jiménez W
Sci Rep; 2019 Sep; 9(1):12848. PubMed ID: 31492960
[TBL] [Abstract][Full Text] [Related]
38. Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis.
Oró D; Yudina T; Fernández-Varo G; Casals E; Reichenbach V; Casals G; González de la Presa B; Sandalinas S; Carvajal S; Puntes V; Jiménez W
J Hepatol; 2016 Mar; 64(3):691-8. PubMed ID: 26519601
[TBL] [Abstract][Full Text] [Related]
39. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
[TBL] [Abstract][Full Text] [Related]
40. Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis.
Parra-Robert M; Casals E; Massana N; Zeng M; Perramón M; Fernández-Varo G; Morales-Ruiz M; Puntes V; Jiménez W; Casals G
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31470518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
